PAREXEL - Shogo Nakamori Speaks About New Joint Program for Clinical Research in Japan
In Japan, clinical trial management is not widely taught in an academic setting. In partnership with Kyoto Pharmaceutical University, we are offering a unique educational program that provides a functional foundation in clinical research and clinical trial management. We believe this program is an innovative way to accelerate the penetration of global standard of clinical research and also solution to the current experienced workforce shortage in Japan. The Joint Program for Clinical Research and Clinical Trial Management offers 5th grade undergraduate students an accredited, seven-week course in clinical research and clinical trial management consistent with global clinical trial standards and practices designed to prepare students for careers in the biopharmaceutical industry. The collaboration is designed to meet the needs of a growing number of pharmaceutical companies conducting clinical research inside and outside of Japan as part of global drug development initiatives. The agreement combines PAREXEL’s extensive regulatory and clinical research expertise with Kyoto Pharmaceutical University’s extensive experience developing highly-specialized research abilities in their “pharmacist-scientists” students. When I retrospect my more than 30 years career in drug development, the first exposure to global standard of drug development including decision making processes was 7-8 years after joined a company. That was the start of learning global way, and it’s too late compare with other countries. Also, English capability is another challenge for Japanese. Success of this joint program means acceleration of penetration of global standard in any related area for drug development in Japan. Under this agreement, 20-25 students a term can enroll in the new course. All classes will be conducted in English by non-Japanese lecturers from the PAREXEL Academy to give students a real-world simulation of conversation and discussion in English as a standard language in the biopharmaceutical sector. The first session of the Joint Program for Clinical Research Management begins in KPU’s fiscal year 2016 and will be offered annually.